3.56
price up icon7.88%   0.26
after-market After Hours: 3.65 0.09 +2.53%
loading
Terns Pharmaceuticals Inc stock is traded at $3.56, with a volume of 1.24M. It is up +7.88% in the last 24 hours and up +39.06% over the past month. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$3.30
Open:
$3.32
24h Volume:
1.24M
Relative Volume:
1.09
Market Cap:
$266.26M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-2.697
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
+16.72%
1M Performance:
+39.06%
6M Performance:
-48.70%
1Y Performance:
-29.92%
1-Day Range:
Value
$3.315
$3.58
1-Week Range:
Value
$2.84
$3.58
52-Week Range:
Value
$1.865
$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name
Name
Terns Pharmaceuticals Inc
Name
Phone
650-525-5535 EXT.101
Name
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Name
Employee
59
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
TERN's Discussions on Twitter

Compare TERN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TERN
Terns Pharmaceuticals Inc
3.56 266.26M 0 -95.90M -79.09M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
498.86 126.60B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
590.00 64.75B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
639.90 36.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.13 31.40B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
102.43 28.98B 2.98B -717.57M -264.74M -2.9987

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Initiated William Blair Mkt Perform
Oct-31-24 Initiated Oppenheimer Outperform
Jun-22-23 Initiated Mizuho Buy
Jun-07-23 Initiated Jefferies Buy
May-31-23 Initiated ROTH MKM Buy
May-08-23 Initiated BMO Capital Markets Outperform
Feb-14-23 Initiated JMP Securities Mkt Outperform
Feb-07-23 Initiated UBS Buy
Sep-12-22 Initiated H.C. Wainwright Neutral
Sep-14-21 Resumed Goldman Buy
Mar-02-21 Initiated Cowen Outperform
Mar-02-21 Initiated Goldman Buy
Mar-02-21 Initiated JP Morgan Overweight
View All

Terns Pharmaceuticals Inc Stock (TERN) Latest News

pulisher
May 01, 2025

Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference - The Manila Times

Apr 30, 2025
pulisher
Apr 30, 2025

Terns Pharma Leaders to Reveal Latest Oncology and Obesity Drug Pipeline Updates at Major Conference - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

An Analysis of Terns Pharmaceuticals Inc (TERN)’s Potential Price Growth - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Terns Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Terns Pharmaceuticals Inc (NASDAQ: TERN) Stock Could Make A -543.09% Loss - Marketing Sentinel

Apr 30, 2025
pulisher
Apr 29, 2025

Analyzing Ratios: Terns Pharmaceuticals Inc (TERN)’s Financial Story Unveiled - DWinneX

Apr 29, 2025
pulisher
Apr 27, 2025

Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87 - DWinneX

Apr 27, 2025
pulisher
Apr 25, 2025

A Look at Terns Pharmaceuticals Inc (TERN) Shares in the Recent Past Indicates Growth - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

TERN overperforms with a 2.86 increase in share price - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Geode Capital Management LLC Has $8.40 Million Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

A company insider recently sold 952 shares of Terns Pharmaceuticals Inc [TERN]. Should You also Consider to Sale? - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

An Analysis Of Terns Pharmaceuticals Inc (TERN) Stock - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 23, 2025

We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate - Yahoo Finance

Apr 23, 2025
pulisher
Apr 22, 2025

TERN’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

Terns Pharmaceuticals (NASDAQ:TERN) Receives Market Outperform Rating from JMP Securities - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates - ADVFN

Apr 21, 2025
pulisher
Apr 18, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Stock Position Raised by LPL Financial LLC - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Alliancebernstein L.P. Has $2.01 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Vanguard Group Inc. Has $21.44 Million Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Mizuho maintains Outperform on Terns Pharma, $14 target By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 14, 2025

Obesity Drug Developers Rise on M&A Hopes After Pfizer Setback - Bloomberg.com

Apr 14, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Purchases 28,330 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

TERN Shares Experience Decline in Value - knoxdaily.com

Apr 11, 2025
pulisher
Apr 10, 2025

Norges Bank Acquires New Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Apr 10, 2025
pulisher
Apr 07, 2025

Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround - Yahoo Finance

Apr 07, 2025
pulisher
Apr 07, 2025

Such Is The Power Of Terns Pharmaceuticals Inc (NASDAQ: TERN) - stocksregister.com

Apr 07, 2025
pulisher
Apr 03, 2025

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) - Yahoo Finance

Apr 03, 2025
pulisher
Apr 02, 2025

Terns pharmaceuticals chief medical officer sells $2,365 in stock By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Terns pharmaceuticals chief medical officer sells $2,365 in stock - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Terns Pharmaceuticals stock hits 52-week low at $2.5 - Investing.com India

Apr 02, 2025
pulisher
Apr 01, 2025

Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN

Apr 01, 2025
pulisher
Mar 31, 2025

Insider Purchases Worth US$5.17m See Losses As Terns Pharmaceuticals Market Value Drops To US$255m - simplywall.st

Mar 31, 2025
pulisher
Mar 31, 2025

HighTower Advisors LLC Invests $468,000 in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Average Price Target from Analysts - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Terns Pharmaceuticals Reports 2024 Progress and Outlook - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Terns Pharmaceuticals stock hits 52-week low at $3.08 - Investing.com

Mar 26, 2025
pulisher
Mar 25, 2025

Bank of New York Mellon Corp Raises Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from William Blair - Defense World

Mar 23, 2025

Terns Pharmaceuticals Inc Stock (TERN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$72.64
price up icon 0.89%
$20.93
price down icon 1.04%
$32.48
price down icon 1.04%
$24.67
price up icon 2.28%
biotechnology ONC
$255.64
price down icon 1.61%
$102.43
price down icon 1.65%
Cap:     |  Volume (24h):